• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

BX-912

This study continues to be undertaken to explore the therapeutic ramifications

February 22, 2019 by Katherine Lewis Leave a Comment

This study continues to be undertaken to explore the therapeutic ramifications of deguelin and specific siRNAs in HeLa cells. interpreted to imply that deguelin serves through several choice pathways and for that reason can be utilized as effective healing agent. Introduction Several natural compounds have already been shown to possess apoptotic activity against a number … [Read more…]

Posted in: Blogging Tagged: BX-912, IFNA1

Objective: While type 1 programmed cell death (apoptosis) of T cells

February 20, 2018 by Katherine Lewis Leave a Comment

Objective: While type 1 programmed cell death (apoptosis) of T cells leads to immunosuppression in sepsis, a crosstalk between apoptosis and autophagy (type 2 programmed cell death) has not been shown. the gene expression of Bcl-2-like 11 and programmed cell death 1. Furthermore, mitochondrial accumulation in T cells occurred via a blockade of autophagy during … [Read more…]

Posted in: Blogging Tagged: BX-912, GFAP

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by